Disclosures for "Development of a Novel Patient-reported Outcome Measure of Functional Impacts for Narcolepsy Types 1 and 2"
-
Dr. romero has received personal compensation for serving as an employee of Takeda. Dr. romero has stock in Takeda.
-
Dr. Savva has stock in Takeda. Dr. Savva has stock in Thermo Fischer.
-
Dr. Crawford has received personal compensation for serving as an employee of Takeda. Dr. Crawford has stock in Takeda.
-
Dr. McPherson has received personal compensation for serving as an employee of Clinical Outcomes Solutions.
-
Dr. Doll has nothing to disclose.
-
Dr. Howerter has received personal compensation for serving as an employee of Clinical Outcomes Solutions.
-
Dr. Symonds has nothing to disclose.
-
Dr. Swick has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Swick has stock in Takeda Pharmaceuticals.
-
Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel.